Convergence Investment Partners, LLC Neogenomics Inc Transaction History

Convergence Investment Partners, LLC

  • $431 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 23, 2019
SELL
$19.57 - $24.1 $169,221 - $208,392
-8,647 Closed
0 $0
Q1 2019

May 01, 2019
SELL
$12.14 - $20.46 $137,643 - $231,975
-11,338 Reduced 56.73%
8,647 $177,000
Q4 2018

Feb 13, 2019
BUY
$11.24 - $18.5 $224,631 - $369,722
19,985 New
19,985 $252,000

Others Institutions Holding NEO

# of Institutions
296
Shares Held
125M
Call Options Held
698K
Put Options Held
116K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.77B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Convergence Investment Partners, LLC Portfolio

Follow Convergence Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email